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The structural basis for receptor recognition
of human interleukin-18
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Interleukin (IL)-18 is a proinflammatory cytokine that belongs to the IL-1 family and plays an
important role in inflammation. The uncontrolled release of this cytokine is associated with
severe chronic inflammatory disease. IL-18 forms a signalling complex with the IL-18 receptor
a (Ra) and b (Rb) chains at the plasma membrane, which induces multiple inflammatory
cytokines. Here, we present a crystal structure of human IL-18 bound to the two receptor
extracellular domains. Generally, the receptors’ recognition mode for IL-18 is similar to IL-1b;
however, certain notable differences were observed. The architecture of the IL-18 receptor
second domain (D2) is unique among the other IL-1R family members, which presumably
distinguishes them from the IL-1 receptors that exhibit a more promiscuous ligand recognition
mode. The structures and associated biochemical and cellular data should aid in developing
novel drugs to neutralize IL-18 activity.
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I
nterleukin (IL)-18 belongs to the IL-1 superfamily and was
first discovered as an interferon gamma (IFN-g)-inducing
factor in sera from mice with hepatitis stimulated with
Propionibacterium acnes and lipopolysaccharide1. This
proinflammatory cytokine is secreted by various types of cells
and strongly augments IFN-g production in type-1 helper T (Th1)
cells and natural killer (NK) cells following activation of NK-cell
cytotoxicity; thus, it plays a critical role in inflammation and the
host defense against microbes. In addition to IL-1b2,3,
IL-18 is synthesized as a biologically inactive precursor (proIL-
18) on activation of a certain class of receptors, such as Toll-like
receptors and proinflammatory cytokine receptors, and then stored
in the cytosol. Once it matures via caspase-1 (ref. 4), which is
regulated by a large protein complex referred to as the
inflammasome5, IL-18 is extracellularly secreted and binds
IL-18 receptor a (Ra) as well as IL-18 receptor b (Rb) at the
immunocyte plasma membrane in a stepwise manner. IL-18/
IL-18Ra/IL-18Rb ternary complex formation juxtaposes the
intracellular Toll-Interleukin-1 receptor domains of IL-18Ra and
IL-18Rb, to which the adaptor molecule myeloid differentiation
factor 88 (MyD88) is recruited presumably with the aid of TRAM6.
MyD88 further interacts with IL-1 receptor associating kinase
(IRAK) 4 and IRAK1/2 to form the large molecular assembly
referred to as Myddosome, which subsequently activates IKK via
TRAF6. Finally, the signal activates the NF-kB and mitogen-
activated protein kinase pathways7, which upregulate the
expression of various inflammatory cytokines.
Of the IL-1 family cytokines, IL-18 and IL-1b have garnered
much attention because they are causal cytokines that lead to
severe chronic inflammatory syndrome. IL-1b is associated with
immunological disorders, such as autoinflammatory syn-
dromes8,9. The central pathogenic feature of autoinflammatory
syndromes is excess production of mature IL-1b derived from
abnormal inflammasome activation due to certain gene
mutations. IL-1b-related autoinflammatory diseases are treated
through neutralizing IL-1b by anti-IL-1b (canakinumab and
gevokizumab), engineered soluble receptors (rilonacept) or the
receptor antagonist IL-1Ra (anakinra), which is remarkably
effective; thus, these treatments are currently in clinical use10.
Similar to IL-1b, IL-18 overproduction likely leads to severe
autoimmune, autoinflammatory, allergic, neurological and
metabolic disease, which might be associated with IL-18 or
IL-18 receptor genetic polymorphisms11–14. Two recent papers
have revealed that constitutive activation of the inflammasome
caused by single point mutations in NLRC4 is associated with a
novel autoinflammatory disorder, and the patient with NLRC4-
mediated macrophage activation syndrome showed ultra-high
circulation levels of IL-18 even after IL-1 blockade15,16.
Consistent with these observations, therapeutic approaches that
block IL-18 activity have been effective in inflammatory disease
models17,18. Therefore, developing drugs that impede binding
between IL-18 and the receptors is clinically important. Generally,
the atomic structures of targeted proteins and their complexes
play vital roles in drug design. Thus far, despite the reported
structures for free IL-18 and its related complexes19–22, a
structure for the genuine complex between IL-18 and its
receptors has not yet been determined.
Previously, we reported a solution structure for IL-18 and
identified the functional residues for which mutation markedly
decreased its binding affinity for IL-18Ra19. The results suggest
that the binary complex between IL-18 and IL-18Ra exhibits an
essentially identical binding mode to the complex between IL-1b
and its receptors (IL-1RI or IL-1RII). However, the binding mode
for IL-18Rb, which is the IL-18 co-receptor, to IL-18/IL-18Ra
remained ambiguous. Recent structural studies on the ternary
complex between IL-1b and its receptors’ ectodomains23,24
demonstrate that IL-1RAcP, which is the commonly used
co-receptor for IL-1a, IL-1b, IL-33 and IL-36s, adopted a ‘left’
binding mode. In this mode, IL-1RAcP binds the IL-1b/IL-1RI or
IL-1b/IL-1RII binary complexes from the left side as seen from
the concave IL-1b recognition surface of IL-1RI or IL-1RII.
Furthermore, the other IL-1 superfamily molecule, IL-33/ST2/IL-
1RAcP, was also suggested to adopt the ‘left’ binding mode based
on the model structure from the small angle X-ray scattering
(SAXS) profiles25. Thus, left binding seems common in
complexes that employ IL-1RAcP. In contrast to other IL-1
family cytokines, IL-18 is unique due to its pair of specialized
receptors (IL-18Ra and IL-18Rb); hence, the recognition details
are not sufficiently understood based only on homology to the
IL-1b and IL-33 system.
Here, we performed X-ray crystallography using human IL-18
and its complexes with the receptors’ extracellular domains. The
structures demonstrate that the co-receptor (IL-18Rb) binding
mode is generally identical to IL-1b; however, substantial
differences were observed in the subdomain orientations and
interaction details throughout the complex. Intriguingly, the
second domain (D2) of the two IL-18 receptors lacked one
b-strand, d2, which is conserved among other IL-1-related
receptors, and was previously shown to contribute to the inter-
receptor interaction. In addition, N-linked glycans played a role
in bridging the two receptors, which was observed in the
signalling IL-1b receptor complex but was absent in its decoy
complex. We further show that other IL-18Ra N-linked glycans
proximal to IL-18 in the complexes contributed to the binding
affinity. With the associated biochemical and cell biological data,
the structures comprehensively clarify the IL-18 receptor
recognition mode, which will facilitate rational drug development
to neutralize IL-18 activity, the uncontrolled release of which has
been shown to cause severe chronic inflammatory diseases.
Results
Structural comparison between the IL-18 and IL-1b complexes.
We determined the crystal structures of IL-18 (Fig. 1a), the IL-18/
IL-18Ra binary complex (Fig. 1b) and the IL-18/IL-18Ra/IL-
18Rb signalling ternary complex (Fig. 1c,d) at the resolutions
2.33, 3.10 and 3.10 Å, respectively. The crystallographic statistics
are provided in Table 1.
IL-18Ra curls around IL-18, and IL-18Rb contacts the lateral
portion of the IL-18/IL-18Ra binary complex in a similar manner
as the IL-1b/IL-1RI(RII)/IL-1RAcP complex23,24. The IL-18
structure essentially does not change on complex formation,
maintaining the b-trefoil fold that comprises 12 b-strands
(b1-b12) and 2 a-helices (a1-a2) (Supplementary Fig. 1a), as
previously reported19. The IL-18Ra ectodomain folds into three
immunoglobulin (Ig)-like domains, which are referred to as D1,
D2 and D3, in the same manner as the IL-1 receptors23,24,26. Each
domain comprises a two-layer sandwich of six to nine b-strands
and contains at least one intra-domain disulfide bond
(Supplementary Fig. 1b). Within IL-18Ra, D1 extensively
contacts D2, whereas D3 is distant and is connected by the
long D2-D3 linker (Fig. 1d middle), which implies that D1 and
D2 behave as a single module, similar to IL-1-related primary
receptors. In the Ig superfamily, including the IL-1 receptor
family (Fig. 2a), the core cysteine residues on the b and f strands
are highly conserved (Fig. 2b). However, for IL-18Ra-D1, the f
strand cysteine is replaced with phenylalanine (Fig. 2b), which
yields two unexpected surface disulfide bonds (Fig. 2c). In
addition, the D2 domain lacks one b-strand (d2 in Fig. 2b,d) that
is structurally conserved among most IL-1 receptor family
members, IL-1RI, IL-1RII and ST2 as well as IL-1RAcP.
On ternary complex formation, the IL-18/IL-18Ra binary
complex structure essentially does not change; the root mean
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square deviations (RMSD) for the backbone Ca atoms are
0.41–0.90Å compared with the asymmetric unit (ASU) mole-
cules. IL-18Rb is also composed of three Ig-like domains, similar
to IL-18Ra except for the aforementioned disulfide bonds
(Supplementary Fig. 1c); however, the spatial arrangement of
these domains is markedly distinct from IL-18Ra in the ternary
complex (Fig. 1d). D2 and D3 of IL-18Rb are close to each other
and directly associated with IL-18/IL-18Ra, while D1 does not
contribute to ternary complex formation. In fact, a part of the
IL-18Rb-D1 electron density is ambiguous presumably because
the region was loosely packed in the crystal (Supplementary
Fig. 2). The D1 isolation of the co-receptor was also observed
previously in the IL-1b/IL-1RI(RII)/IL-1RAcP complex, where
IL-1RAcP-D1 is outstretched and does not participate in the
molecular interface. Despite of the similarity in the binding mode,
relative orientation of IL-18Rb-D2þD3 to IL-18/IL-18Ra is
different from that of IL-1RAcP-D2þD3 to IL-1b/IL-1RI(RII)
(Fig. 3a–c). This difference in the orientations is attributable to
the interaction manner at the interface between IL-18Rb-D2 and
IL-18/IL-18Ra (Fig. 3b,d). Owing to the aforementioned absence
of the d2 strands in D2s (Fig. 2b,d), IL-18Ra-D2 and IL-18Rb-D2
supply only two strands (b2 and e2) and loops at the interface,
respectively, while for IL-1RI(RII) and IL-1RAcP-D2, three
strands (b2, e2 and d2) and loops interact (Fig. 1d and
Fig. 3a–c). Furthermore, IL-18Rb-D2 supplies not only electro-
static side chains but also aromatic rings that interact with IL-18,
whereas IL-1RAcP-D2 utilizes electrostatic and aliphatic side
chains for ligand binding. The b4-b5 loop of IL-18 and IL-18Rb-
D3 do not interact, which may also contribute to the orientation
difference (Fig. 3d). A more marked dissimilarity is observed for
the IL-18Rb-D1 orientation relative to -D2, which differs from
IL-1RAcP in the complex (Fig. 3e). As a result, despite the same
‘left’ binding mode, the spatial arrangements of the subdomains
in the IL-18/IL-18Ra/IL-18Rb ternary complex differ somewhat
from IL-1b/IL-1RI/IL-1RAcP with Ca atom RMSD values of
6.64–6.73Å.
The binding interface between IL-18 and IL-18Ra. IL-18Ra
recognizes IL-18 through a large interaction surface area at
B1,850Å2. Two IL-18 sites, Sites I and II, contact IL-18Ra; Site I
is located on a side of the core barrel of the b-trefoil structure,
and Site II is at the top of the b-barrel (Fig. 4a).
Our previous NMR study showed that the residues 34 to 42 are
flexible despite partial a-helix formation in this region (residues
38–41)19. In addition, two isomeric forms that originate from a
cis or trans peptide bond between Ala42IL-18-Pro43IL-18 in the
loop are equally populated in the solution structure. The flexible
nature of the segment produces a variety of architectures, as
demonstrated in several crystallographic reports, including a loop
with a trans isomer22, an a-helix with a cis isomer21 or, primarily,
unobservable flexible loop with a trans isomer20,22 (Fig. 4a–c). In
both the binary and ternary complexes, the segment between
residues 35 and 40 adopts an a-helix structure with a cis
Ala42IL-18-Pro43IL-18 bond, which is stabilized by hydrogen
bonds and electrostatic interactions with IL-18Ra (Fig. 4c).
Surrounding Site I, a-helix I mediated the interaction (Fig. 4c
and Fig. 5a), wherein the Arg25Ra side chain is buried within the
b3-a1 acidic groove of IL-18. Two disulfide bonds, Cys22Ra-
Cys41Ra and Cys43Ra-Cys81Ra, bridge the b1-c1 loop to the
N-terminal loop and d1-e1 turn, respectively (Figs 2c and 5a),
which likely reinforce the proximal loop structure, to which the


















Figure 1 | Overall structures for IL-18 and its extracellular complexes. (a–c) Schematic flow diagram of the stepwise complex formation for IL-18/
IL-18Ra/IL-18Rb. Crystal structures of (a) IL-18, (b) IL-18/IL-18Ra and (c) IL-18/IL-18Ra/IL-18Rb are shown as a ribbon (IL-18, blue) or surface (IL-18Ra,
palegreen; IL-18Rb, wheat) representation, respectively. (d) Ribbon diagrams of the ternary complex structure for IL-18 (blue), IL-18Ra (green) and
IL-18Rb (orange) from three perspectives.
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implies that the loop structure may be loosened under certain
reductive conditions, which affects the affinity for the ligand.
The Ser42Ra amide proton supplies a hydrogen bond for the
Asp132IL-18 side chain, which also exhibited a backbone–
backbone hydrogen bond with Cys22Ra. Around Site II
(Fig. 5b), the IL-18Ra acidic surface, which is composed of the
Glu253Ra and Glu263Ra carboxylates as well as Trp249Ra
backbone oxygen, captures the Lys53IL-18 e-amino group.
IL-18Rb recognition by IL-18/IL-18Ra. The IL-18/IL-18Ra/IL-
18Rb signalling ternary complex is formed by IL-18Rb binding
with the lateral portion of the binary complex (Fig. 1). The
IL-18Rb-D2 convex surface with the key Tyr212Rb aromatic
residue fits into the concave surface jointly formed by IL-18 and
IL-18Ra-D2 (Fig. 5c and Supplementary Fig. 3a) with a 613Å2
buried surface area, which is shallower than that in the IL-1b
complexes. The concave surface area is divided into Site III on
IL-18 (354Å2, Fig. 5c) and part of IL-18Ra-D2 (259Å2,
Supplementary Fig. 3a). Note that IL-18 Site III is revised in this
work19. Site III of IL-18 comprises the prominent b8-b9 hairpin
and b11-a2 loop (Fig. 5c), where the aromatic ring of His109IL-18
forms p-p stacking with Tyr212Rb at a 3.4 Å distance, which is
surrounded and stabilized by multiple hydrogen bonds. IL-18Ra-
D2 is composed of an antiparallel b-sheet formed by b2 and e2
(Supplementary Fig. 3a) but lacks the conserved d2 strand
compared with the corresponding b-sheets of IL-1RI and ST2.
Although the structure of IL-36R has not been determined yet,
the multiple sequence alignment suggests that the b2/e2/d2
sheet is conserved among the primary receptors (Fig. 1b and
Supplementary Fig. 1b). In addition to these interactions,
IL-18Rb-D3 extensively contacts IL-18Ra-D3 with the buried
area B550Å2, to which both electrostatic (Supplementary
Fig. 3b) and hydrophobic interactions (Supplementary Fig. 3c)
contribute. These inter-receptor interfaces in the IL-1b complex
are designated as Site IV23, in which the IL-1b b4-b5 loop
interacts with IL-1R1-D3 and IL-1RAcP-D3 to at least partly
establish the ligand’s agonism/antagonism. The same would be
true for the IL-36 system based on the crystal structure of IL-36
(ref. 27). In contrast, the corresponding IL-18 loop does not
contact IL-18Rb-D3 and only interacts with IL-18Ra-D3 (Fig. 3d).
N-linked IL-18Ra glycans and its interactions. In the IL-18/IL-
18Ra and IL-18/IL-18Ra/IL-18Rb crystal structures, seven
N-linked glycosyl chains were identified in IL-18Ra at Asn91,
102, 150, 197, 203, 236 and 297 (Fig. 6a). These carbohydrates are
high-mannose glycans (Fig. 6b) because the receptor proteins
were prepared using the Sf9 expression system. The glycan on
Asn197Ra, which are located in the D2 domain, forms moderate
intramolecular interactions with Arg114Ra and His117Ra at the
D1-D2 loop (Fig. 6c), seemingly contributing to the subdomains’
spatial arrangement. The core-NAG (N-acetyl-D-glucosamine)
directly linked to Asn297Ra branches into the second-NAG and
L-fucose (FUC), which is referred to as the core-FUC (Fig. 6b–d).
Interestingly, the core-FUC and second-NAG on Asn297Ra are
proximal to the b4-b5 loop of IL-18 (o4Å); hence, they likely
interact through electrostatic and hydrophobic interactions with
the ligand (Fig. 6d) and partly contribute the unique D3:D3
interaction.
Notably, the NAG-NAG extended from the IL-18Ra-D3
Asn236Ra and points to the receptor C-terminus in the binary
complex; however, in the ternary complex, the NAG-NAG chain
changes direction and points to IL-18Rb-D3 within the distance
possibly to form electrostatic interaction with Val257Rb and
Asp259Rb (Fig. 6e). A similar inter-receptor interaction via an
Table 1 | X-ray crystallographic statistics of IL-18 and its extracellular complexes.
IL-18 IL-18/IL-18Ra IL-18/IL-18Ra/IL-18Rb
Data collection
Beamline BL38B1 (SPring-8) BL44XU (SPring-8) BL17A (Photon Factory)
Wavelength 1.0000 0.9000 0.9800
Space group P21 P21212 P212121
Cell dimensions
a, b, c (Å) 68.15, 79.51, 73.46 135.49, 174.81, 183.40 72.56, 111.56, 134.57
a, b, g () 90.00, 100.97, 90.00 90.00, 90.00, 90.00 90.00, 90.00, 90.00
Resolution (Å) 45.0–2.33 (2.46–2.33) 43.9–3.10 (3.27–3.10) 50.0–3.10 (3.21–3.10)
Rmerge 4.9 (39.6) 10.0 (58.2) 11.5 (68.3)
I/sI 20.5 (3.6) 14.9 (2.5) 19.8 (2.9)
Completeness (%) 97.8 (97.1) 99.6 (100) 99.9 (99.3)
Redundancy 3.8 (3.8) 3.7 (3.8) 9.8 (9.2)
Refinement
Resolution (Å) 34.82–2.33 (2.41–2.33) 42.00–3.10 (3.18–3.10) 42.00–3.10 (3.29–3.10)
No. reflections 32,157 (2,861) 79,130 (5,821) 17,368 (1,825)
Rwork/Rfree 21.8/27.1 (27.6/29.8) 19.1/22.2 (22.7/26.3) 18.8/23.2 (20.9/29.7)
No. atoms
Protein 5,022 20,533 5,663
Glycan — 1,225 335
Others 711 289 32
B-factors
Protein 46.13 78.31 74.38
Glycan — 121.43 139.74
Others 60.94 109.02 36.55
R.m.s. deviations
Bond lengths (Å) 0.010 0.009 0.009
Bond angles () 1.38 1.11 1.17
Ramachandran plot 95.2, 4.8 94.4, 5.0, 0.5 93.7, 5.4, 0.8
Values for Ramachandran plots are presented as favoured, allowed, outlier examined by RAMPAGE. Data collection statistics were summarized from the report35.
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N-linked oligosaccharide was previously observed between
IL-1RI-D3 and IL-1RAcP-D3 in the IL-1b signalling complex,
but it is intriguingly absent in the IL-1b/IL-1RII/IL-1RAcP
non-signalling decoy complex, which suggests that the N-linked
oligosaccharides bridging the two receptors are important for
IL-1 family signal transduction.
Characterization of IL-18/IL-18Ra/IL-18Rb in solution. A
previous SPR analysis showed that IL-18Rb does not bind free
IL-18, but it does bind a preformed IL-18/IL-18Ra binary
complex19. To better understand the formation of this complex
under more physiological conditions, we performed titration
experiments using solution NMR spectroscopy. The 1H–15N
correlation spectrum for [2H,15N]-IL-18 did not change on
adding a small excess of IL-18Rb, indicating that the molecules do
not interact. However, marked spectral changes were observed
when IL-18 was titrated with IL-18Ra (Supplementary Fig. 4a,b).
The amino-acid residues that were perturbed during the titration
are at the molecular interface of the binary complex,
which indicates that the binding mode in solution is identical
to the crystal structure (Supplementary Fig. 4b, bottom).
Cross-saturation NMR experiments28 further confirmed this
result with more precision (Fig. 7a, forest and Supplementary
Fig. 4c). Next, IL-18Rb was added to the preformed [2H,15N]-IL-
18/IL-18Ra binary complex. The 1H–15N correlation spectrum
was then changed due to ternary complex formation. Although
significant changes were not observed in the region including the
previously defined Site III (Supplementary Fig. 4d), the cross-
peaks that disappeared or shifted on ternary complex formation
(Supplementary Fig. 4e) are mostly at the interface with IL-18Rb,
which is consistent with the ternary complex crystal structure
(Fig. 7a, orange). Furthermore, we performed SAXS to analyse the
architecture of the ternary complex (Supplementary Fig. 4f–h);
these data were used to construct a low-resolution dummy atom
model. The crystal structure of the complex reasonably fits the
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Figure 2 | Structural features of IL-18 and its receptors. (a) Promiscuous interactions between the IL-1 family agonists and IL-37 with the receptor
molecules. Except IL-18, all agonists employ IL-1RAcP as a co-receptor, while IL-18 uses IL-18Rb. (b) Certain regions of the receptor multiple sequence
alignments manifest the unique qualities of IL-1R family IL-18Rs. The full set of sequence alignments is in Supplementary Fig. 1. (c) Structural comparison
of D1 and (d) D2 of the receptors from the signalling complex. The green circles in (c) show the disulfide bond positions.
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Figure 3 | Structural comparison of the IL-1 family cytokine ternary complexes. (a) Structural alignment of IL-18/IL-18Ra/IL-18Rb (blue) and IL-1b/IL-1RI/
IL-1RAcP (4DEP, red) using the binary complex region. The backbone Ca RMSD between IL-18/IL-18Ra and IL-1b/IL-1RI is 4.35–4.36Å. (b) The orientation
of D2 and D3 from IL-18Rb and IL-1RAcP in the complexes. The dotted lines show the approximate orientation of the longitudinal D2 and D3 axes.
A close-up of the binary complex interface, which recognizes the co-receptor protein D2 domains, is also shown. (c) A comparison of IL-18/IL-18Ra/
IL-18Rb (blue) and IL-1b/IL-1RII/IL-1RAcP (3O4O, green). The backbone Ca RMSD was 4.39Å surrounding the binary complex portion. (d) A close-up
of the b4-b5 loops of the ligands in IL-18/IL-18Ra/IL-18Rb (left) and IL-1b/IL-1RII/IL-1RAcP (right). (e) Superimposition of IL-18Rb and IL-1RAcP
(from 3O4O). The IL-18Rb-D1 orientation relative to D2 is the opposite of IL-1RAcP.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6340
6 NATURE COMMUNICATIONS | 5:5340 | DOI: 10.1038/ncomms6340 |www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
structures solved in this study are consistent with the data
collected in the solution state, which underscores the
physiological significance of the crystal structures.
Effects of mutation on the signaling and binding affinities. To
confirm the importance of the IL-18 Site III interactions in signal
transduction, we performed cell-based assays using IL-18Rb
mutants (Fig. 8a). IL-18Rb-WT and its mutants were transiently
expressed in HEK293 cells with a background of stably expressed
IL-18Ra; the NF-kB activity was measured using the luciferase
reporter system with or without an IL-18 stimulus. A complete
loss of function was observed for the IL-18Rb-E210A-Y212A-
Y214A triple mutants, while IL-18Rb-E210A, -Y212A and -
K313A exhibited approximately half the activity compared with -
WT. Remarkably, only a minor decrease in activity was observed
when the D1 region of IL-18Rb was deleted (D15–65 and D15–
146, Fig. 8b), likely because IL-18Rb-D1 is distal to the other
parts of the ternary complex and seemingly does not affect
binding. However, a substantial decrease in activity was observed
when the D1-D2 loop (D15–153) was deleted, and the activity was
fully abolished in the D1/D2-deficient experiments (D15–176 and
D15–243). Therefore, IL-18Rb-D2þD3 is sufficient, but D1 is
not essential for signalling.
To identify the amino-acid residues that are critical for ternary
complex formation, we performed a binding study using surface
plasmon resonance (SPR) analysis (Supplementary Figs 5 and 6
and Supplementary Table 1). The prominent binding residues are
summarized in Table 2 and Supplementary Fig. 7. First, IL-18Rb
was immobilized on the sensor chip, and binary complexes that
formed between one of IL-18 mutants and IL-18Ra were
examined for binding. When the binary complex contained
either of three IL-18 mutants, G108A, H109A or K112A, it lost
affinity for IL-18Rb, even though these mutants maintained full
binding activity for IL-18Ra. Thus, the mutated residues are only
important for IL-18Rb binding. Next, one of IL-18Rb mutants
was immobilized on the sensor chip, and the IL-18/IL-18Ra
binary complex was examined for binding. Our data show that
IL-18Rb-Y212A did not bind the binary complex, which is
consistent with the structure, wherein substantial p-p stacking
were observed between Tyr212Rb and His109IL-18 (Fig. 5c).
IL-18Rb-K313A and -E210A exhibited 7- and 20-fold lower
affinity for the IL-18/IL-18Ra complex relative to the wild-type
receptor, respectively. These data are also consistent with the
NF-kB luciferase reporter assay and the structure, wherein
the mutated residues extensively interact with His109IL-18,
Asp110IL-18, Lys112IL-18 and Phe135Ra (Fig. 5c and
Supplementary Fig. 3a).
To determine the contribution of the IL-18Ra N-linked
oligosaccharides to the receptor complex formation, we mutated
two IL-18Ra asparagine residues to glutamine (Table 2). The
affinity of IL-18 for IL-18Ra decreased to one-third when
Asn297Ra was mutated to Gln compared with the wild type,
which indicates that the sugar chain is important for the
recognition of ligand, wherein the Asn297Ra core-FUC and
second-NAG are proximal to IL-18 (Fig. 6d). However, we did
not observe a different affinity on mutating Asn236Ra.
Discussion
It is well-known that the IL-1 family system has only two
co-receptors, IL-1RAcP and IL-18Rb, despite its seven agonists

































IL-18 in complex with IL-18Rα





Figure 4 | IL-18 structural perturbations on binding IL-18Ra or other proteins. (a) Superimposition of the structures of IL-18 in free and various
complex forms: crystal structure of IL-18 with CHPAS (red); the solution structure (1J0S, raspberry); the crystal structure of IL-18 in complex with
Ectromelia virus IL-18BP (3F62, pink); the crystal structure of IL-18 complexed with murine reference antibody 125-2H Fab (2VXT, salmon); the crystal
structure for IL-18 in complex with YLDV 14L IL-18BP (4EEE, brown); the crystal structure for IL-18 in complex with a DVD-Ig molecule (4HJJ, gray);
the crystal structure of IL-18 in complex with IL-18Ra (blue). (b) The zoom window of the dashed line box shown in 2a. (c) The stabilized structure
and IL-18 a-helix I interactions. The structure of IL-18 a-helix I stabilized by interactions with IL-18Ra.
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primary receptors (IL-1RI, IL-18Ra, ST2 and IL-36R)29. Thus,
certain receptors must be used by multiple ligands (Fig. 2a). In
fact, IL-1RAcP is commonly involved in signals with six ligands
other than IL-18, which is recognized by its specific receptors,
IL-18Ra and IL-18Rb. Accordingly, the IL-18 binding mode
remained unclear even after several crystal structures of the IL-1b
and receptor complexes became available. The IL-18 complex
structures determined in this work exhibited essentially the same
binding mode as IL-1b23–25. This feature was confirmed under
more physiological conditions by using two solution techniques,
NMR and SAXS. On the basis of these results, it is highly likely
that the left binding mode is the common mode in the IL-1
family; however, the IL-36/IL-36R/IL-1RAcP ternary complex
structure has not been determined. Although the general binding
mode was conserved, substantial differences were observed at the
ligand-receptor or receptor-receptor interfaces in the IL-18 and
IL-1b ternary complexes, which was expected based on the
significant sequence deviations (Supplementary Fig. 1). The
pronounced effects from such deviations include the unique
compositions of secondary structure elements in IL-18Ra-D1
and IL-18Rs-D2, such as the lack of a b-strand that is
typically conserved among Ig-like domains. This feature has
led to the unique subdomain orientation of IL-18Rb, and may
partly explain why IL-1RAcP exhibits the promiscuous ligand
recognition mode, although IL-18Rb does not. On the basis of the
presumable existence of d2 in IL-36R-D2 and the IL-36
(ref. 27) structure, it is likely that the IL-36 system also
adopts the left binding mode with similar orientation to the
IL-1b system.
Furthermore, we found a potential common trait among
the IL-1 family, which is that the N-linked glycans presumably
bridge two receptors in the ternary complex. Intriguingly, this
feature was only observed in two functional ternary complexes
(IL-1b/IL-1RI/IL-1RAcP and IL-18/IL-18Ra/IL-18Rb) but was
absent in the decoy ternary complex (IL-1b/IL-1RII/IL-1RAcP)
and may contribute the binding affinity. Nevertheless, our SPR
analyses showed that the difference in IL-18Ra-binding affinity
for IL-18Rb was only trivial even without glycosylation
(N236QRa in Table 2). This discrepancy may be due to the
distinct sugar modification patterns between insects and
mammals. N-glycans are mostly pauci-mannose (Fig. 6b, not
greater than three MAN) oligosaccharides in silkworm30, while
mammals contain more varied outer sugar chains; certain chains
are longer with more complicatedly mixtures (that is, MAN,
NAG, galactose and sialic acid). Thus, larger interaction surfaces
on N236Ra sugar chains in humans are expected, which could
strengthen the affinity. In contrast, one N-glycan chain likely
plays a unique role in the IL-18 system, as the IL-18Ra Asn297Ra
sugar chain moderately interacts with IL-18 in both the binary
and ternary complexes (Fig. 6d). In fact, IL-18Ra without the
sugar chain (N297Q) exhibited a threefold lower binding affinity
(Table 2). To our best knowledge, such sugar–ligand interactions
have not been reported for other IL-1 family members. For the
IL-1b complexes, any N-glycan chains on IL-1RI(RII) appear too
distal to the ligand for direct contact.
IL-1 family activity in vivo are modulated by the counteractions
of natural inhibitors, such as receptor antagonists (IL-1Ra,












































































Figure 5 | The key residues involved in forming the ternary signalling complex. (a) The interactions in the IL-18 receptor binding Site I. In addition
to the area surrounding the stable a-helix I, Asp132IL-18 at the tip of the b10-b11 hairpin exhibits ionic interactions with the structure, which are formed by
the two unique disulfide bonds in IL-18Ra. (b) Interactions surrounding the IL-18 Site II. The key residue of Lys53IL-18 is recognized by the IL-18Ra acidic
surface through multiple hydrogen bonds. (c) The interface between Site III of IL-18 and IL-18Rb. In addition to His109IL-18/Tyr212Rb stacking, multiple
hydrogen bonds were observed: the His109IL-18 Ne-H to the Val211Rb backbone carbonyl oxygen as well as the Lys112IL-18 Nz-H to the Glu210Rb side chain
and Tyr212Rb OZ.
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sST2) and IL-18BP. These proteins tightly bind their target
cytokines or receptors, which impedes formation of ternary
complexes that initiate intracellular signal transduction. This
balancing feature facilitates secure control of inflammatory
responses in vivo. Our structures not only demonstrate the
receptors’ molecular recognition mode for IL-18, but they
also explain the IL-18 inhibitors’ mechanism of action.
Superimposition of the IL-18/IL-18Ra and IL-18/IL-18BPs
complex structures20,22 shows that the IL-18BP binding site on
IL-18 precisely corresponds with the IL-18Ra-D3 binding site.
Thus, IL-18BP clearly inhibits IL-18Ra binding through steric
hindrance (Supplementary Fig. 8a). Recently, IL-37 (IL-1F7b) was
proposed to function as an anti-inflammatory cytokine31. IL-37
weakly bound IL-18Ra with 50 times lower affinity than IL-18
 
 


































Pauci-mannose (for SPR)Asn102 Asn203
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α1,2
Figure 6 | The sugar contacts that maintain IL-18/IL-18Ra/IL-18Rb. (a) The N-linked glycans identified from the structure. (b) The N-linked glycosylation
in this study. (c) Intramolecular interactions between the carbohydrates on Asn150Ra and His190Ra as well as on Asn197Ra and the D1-D2 loop.
(d) Interactions between the N-linked carbohydrates on Asn297Ra and IL-18. Core-FUC moderately interacts with IL-18 at an B4Å distance.
(e) Interactions between the N-linked carbohydrates on Asn236Ra and IL-18Rb.
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(Fig. 2a), and did not activate signal transduction32. Consistent
with this notion, the essential IL-18 amino acids for the IL-18Rb
interactions, as well as for IL-18Ra, determined in this study are
not conserved in IL-37 (Supplementary Fig. 1a), which suggests
that IL-37 is incapable of forming the ternary complex that
enables signal transduction. In addition to the natural inhibitors,
several anti-IL-18 antibodies have been developed for therapeutic
purposes21,33. The structures herein clearly explain how these
antibodies impede binding between the ligand and receptors
(Supplementary Fig. 8b).
The molecular interface differences herein are important
because they may provide numerous opportunities for designing
molecules that specifically stabilize or interrupt IL-18 ternary
complex formation without affecting other IL-1 family members.
Unlike molecules that target more downstream signalling path-
ways, these molecules can be used to treat ligand-specific diseases
and avoid side effects due to interference with common
intracellular signalling pathways. The structural information
collected in this work will facilitate development of an IL-18
modulator in multiple ways. For example, recombinant deriva-
tives of IL-18, which bind to IL-18Ra more strongly relative to
wild type of IL-18, can be logically designed based on the
structures34. The structures will especially benefit small molecule
design; small molecules are generally more cost effective once
developed, and thus preferable to proteinous compounds. The
data obtained in this study provide an atomic framework for
molecular interfaces between IL-18 and receptors as well as
between the two receptors, which serve as promising drug target




Figure 7 | The solution-state IL-18/IL-18Ra/IL-18Rb binding mode. (a)
The results of cross-saturation experiments with [2H–15N]-IL-18/IL-18Ra
(forest) and the chemical shift change of [2H–15N]-IL-18/IL-18Ra on adding
IL-18Rb (orange) are coloured on the crystal structure of IL-18 in complex
with IL-18Ra and IL-18Rb. (b) Superimposition of the IL-18/IL-18Ra/IL-18Rb
crystal structure and the low-resolution SAXS envelope.
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Figure 8 | The effect of mutations on protein–protein interfaces for
signal transduction. Cell-based NF-kB activity assay for IL-18Rb with
(a) an alanine substitution and (b) N-terminal deletion. Each column
indicates the relative luciferase activity unit (R.L.U.), for the stimulated
cells(þ ) and the non-stimulated cells( ). The data are the mean±s.d. for
triplicate experiments. Asterisks inside the graphs indicate the significance
from comparing mutant versus wild-type IL-18 Rb, which was determined
using a one-way ANOVA with Bonferroni’s multiple comparison test;
*Po0.05. This experiment is representative of three independent
experiments.




Analyte: IL-18 mutant/IL-18Ra WT complex
IL-18 WT(control) 1.5±0.1
IL-18 G108A No binding
IL-18 H109A No binding
IL-18 D110A 5.6±0.8





Analyte: IL-18 WT/IL-18Ra WT complex
IL-18Rb WT (control) 1.5±0.1
IL-18Rb L167A 3.3±0.4
IL-18Rb E210A 32.7±0.9




Analyte: IL-18WT/IL-18Ra mutant complex




IL-18Ra WT (control) 6.9±0.2
IL-18Ra N297Q 25.8±2.6
Ligand: the interactant captured on the sensor surface. Analyte: the interactant in free solution.
WT: wild type. Values are the means±s.d. of the results derived from three independent
experiments.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6340
10 NATURE COMMUNICATIONS | 5:5340 | DOI: 10.1038/ncomms6340 |www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
In summary, the structures of IL-18 and its receptor have
advanced our precise understanding of molecular recognition and
suggest a single architectural paradigm for signalling complexes
in the IL-1 family cytokines. Furthermore, with biochemical and
cellular data, the structures reveal detailed interaction properties
at the molecular interfaces, presenting an atomic framework that
will aid in rational drug development for IL-18-related diseases.
Methods
Construction of expression vectors. The coding region of the extracellular
domains of human IL-18Ra (NM_003855, residues 20–329) and IL-18Rb
(NM_003853, residues 15–356) were cloned into the pFastBac1 vector (Invitrogen,
Carlsbad, CA, USA). Full-length IL-18Rb was also cloned into the pcDNA3.1þ
vector (Invitrogen). The pGL4.32[luc2P/NF-kB-RE/Hygro] vector was used as an
NF-kB luciferase reporter, and the pGL4.70[hRluc] vector was used as an internal
control Renilla luciferase reporter; both were purchased from Promega (Fitchburg,
WI, USA). For the crystallographic studies, the signal-peptide sequence for Sf9
insect cells, an 8His tag and an HRV 3C protease cleavage site were placed
immediately upstream of the mature sequence35. The same constructs with a
C-terminal 6His tag and without the HRV 3C site were also prepared for
solution structure analysis and SPR experiments. Mutations were introduced into
the pGEX4T-1[IL-18]19, pFastBac1[IL-18Rs] and pcDNA3.1þ [IL-18Rb] vectors
using an inverse PCR-based site-directed mutagenesis method.
Protein expression and purification. Mature IL-18 (residues 1–157) and its single
amino-acid mutants were prepared as previously reported19. In brief, human IL-18
was expressed as a glutathione S-transferase (GST) fusion protein in the Escherichia
coli strain BL21(DE3) (Novagen, Madison, WI, USA). GST-tagged IL-18 was
affinity purified followed by GST digestion with Factor Xa and further purified
using gel filtration column chromatography. Expression of IL-18Rs using Sf9 insect
cell system and their detailed purification procedures were also described35. The
extracellular human IL-18Ra or IL-18Rb domains were each separately secreted
from Sf9 insect cells (Invitrogen) for structural analyses. The supernatant was
purified through three chromatography steps, including ion exchange
chromatography, Ni-NTA affinity chromatography and gel filtration
chromatography with or without an HRV 3C treatment. To obtain the IL-18/IL-
18Ra binary and IL-18/IL-18Ra/IL-18Rb ternary complexes, IL-18, IL-18Ra and
IL-18Rb were mixed at equimolar ratios and purified through gel filtration
chromatography. Both the wild type and the mutants of the IL-18Rs for SPR
analysis were expressed using a silkworm system36,37. The donor plasmids of the
pFastBac1 vectors containing the IL-18 receptor gene were transformed into
Escherichia coli BmDH10Bac. Then, 1 mg of BmNPV bacmid DNA and 1ml of
Cellfectin reagent (Invitrogen) suspended in Grace insect cell medium were
injected into the ventral side of B. mori silkworm larvae. After 6 days, haemolymph
was recovered from the larvae, and sodium thiosulfate (final 0.5%) and EDTA
were immediately added. The IL-18 receptor proteins from the silkworm
were purified using the same protocols as the purification from the Sf9 insect
cell system.
Cell culture. HEK293 cells (Japanese Collection of Research Bioresources, Osaka,
Japan) were cultured in Dulbecco’s modified Eagle’s medium (high glucose-
containing D-MEM, Invitrogen) supplemented with 10% heat-inactivated fetal
bovine serum (Sigma-Aldrich, Missouri, USA), penicillin (100 unitml 1) and
streptomycin (100 mgml 1). All cells were incubated at 37 C in a humidified
atmosphere of 5% CO2.
Luciferase reporter gene assay. HEK293 cells were transfected with an
empty pcDNA3.1þ vector or pcDNA3.1þ [IL-18Rb] (wild-type or mutants),
pGL4.32[luc2P/NF-kB-RE/Hygro] and pGL4.70[hRluc] vectors using
Lipofectamine 2000 reagent according to the manufacturer’s instructions. These
transfectants were stimulated with recombinant human IL-18 (10 ngml 1) for 6 h.
The luciferase reporter gene activities were analysed using a Dual-Luciferase
Reporter Assay System (Promega). The statistical significance of the differences was
determined using one-way ANOVA with Bonferroni’s multiple comparison test.
The statistical significance was assigned to be Po0.05.
Surface plasmon resonance analysis. The real-time binding affinities between
IL-18 and IL-18Ra and between IL-18Rb and IL-18/IL-18Ra were analysed using a
BIAcore 3000 surface plasmon resonance spectrometer (GE Healthcare, Little
Chalfont, UK) at 25 C with a Ni-NTA sensor chip. The Kd (dissociation constant)
estimated using the Ni-NTA sensor chip was an average of one order of magnitude
lower than estimates obtained using an Anti-His-tag Ab covalently linked to a CM5
sensor chip. However, we used the Ni-NTA sensor chip because it did not decrease
the binding capacity after repeated measurement cycles, which is desirable when
comparing the Kd of many mutants.
C-terminal 6His tagged IL-18Ra was immobilized approximately
200-resonance units (RU) on an NTA sensor chip. Then, various concentrations of
IL-18 in HBS-P (10mM HEPES-Na, pH7.4, 150mM NaCl, 0.01% (v/v) surfactant
P-20) buffer were injected over the sensor surface as an analyte at a flow rate of
30 ml min 1 for 180 s. After association, it was allowed to run for another 360 s for
dissociation. In the same way, C-terminal 6His tagged IL-18Rb was immobilized
approximately 100 RU on the sensor chip, and un-tagged IL-18Ra that was
saturated with 500 nM IL-18 in HBS-P buffer was injected. The sensor surface
was regenerated with 350mM EDTA. For the mutational analysis, mutants of
IL-18, IL-18Ra and IL-18Rb were used instead of wild type, as shown in
Supplementary Table 1. The sensor chip was analysed using BIAevaluation
software (GE Healthcare). Analyses with the same concentration series were
performed in triplicate.
Crystal structure determination. Step by step crystallization method and pre-
liminary crystallographic analysis were done as described35. X-ray diffraction data
were collected at 100K on the BL38 (IL-18) or BL44XU (IL-18/IL-18Ra) beamlines
at SPring-8 (Harima, Japan) and on the BL17A beamline (IL-18/IL-18Ra/IL-18Rb)
at Photon Factory (Tsukuba, Japan). For IL-18 and IL-18/IL-18Ra, the diffraction
data were processed using the XDS38 and SCALA39,40 software. The initial phases
were determined by molecular replacement using Phaser41 with the crystal
structure of IL-18 (ref. 20) (PDB code: 3F62) as the search model. The initial phases
of the binary complex were improved by NCS averaging using RESOLVE42.
The model was further manually built using COOT43 and refined using BUSTER44
with autoNCS45. In the IL-18 and IL-18/IL-18Ra crystals, four and six copies of
IL-18 and the binary complexes were observed in each ASU, respectively. The
structures of these copies in the ASUs are essentially the same, so we referred to
chain A for IL-18 and chain A/B for IL-18/IL-18Ra, if not otherwise indicated. The
structure of IL-18 included 13 molecules of CHAPS. The diffraction data of IL-18/
IL-18Ra/IL-18Rb were processed using HKL2000 software46. To determine the
initial phase for IL-18/IL-18Ra/IL-18Rb, a refined structure of the binary complex
was used as the search model for molecular replacement. The model was further
manually built using COOT and refined using BUSTER. Only one copy of the
ternary complex was in the IL-18/IL-18Ra/IL-18Rb crystal ASU. Ramachandran
diagrams were examined using RAMPAGE47. Structural figures were prepared
using PyMol (Schro¨dinger, LLC). The secondary structures were assigned using the
DSSP software48.
NMR spectroscopy. All NMR spectra were measured at 308K on a Bruker
Avance II 700MHz spectrometer equipped with cryogenic probes using TROSY-
type pulse sequences. The samples for NMR measurements were in 20mM
potassium phosphate (pH 6.0), 50mM KCl in H2O/D2O (90%/10%). Spectra were
processed using NMRPipe49 and analysed using Sparky analysis software50.
Chemical shift assignments for IL-18 bound to IL-18Ra are based on a
HN(CO)CA/HNCA data set and confirmed by HNCACB and NOESY spectra with
a mixing time of 200ms. The IL-18Ra binding surface of IL-18 in solution is
defined by the cross-saturation28 intensity ratio of I2000ms/I0ms. The IL-18Rb
binding site of IL-18 is inferred from the titration experiment, by shifted or
eliminated peaks, which can be assigned for all but the IL-18Ra binding surface.
Structural figures were prepared using PyMol (Schro¨dinger, LLC).
Small-angle X-ray scattering. SAXS data of the IL-18/IL-18Ra/IL-18Rb ternary
complex were collected at the beamline 12ID-B of the Advanced Photon Source at
Argonne National Laboratory (Argonne, IL, USA). The sample concentrations
were 1, 3 and 5mg 1ml 1. The samples were run at 12 keV radiation energy,
with a sample-to-detector distance of 2m. The scattered X-rays were measured
using a Pilatus 2M detector. A flow cell was used to reduce radiation damage.
Thirty images were taken for each blank and each sample.
After background subtraction, the data were superimposed using Primus51
(Supplementary Fig. 4f). S is the momentum transfer equal to 4psin(y/2)/l, where
y and l are the scattering angle and X-ray wavelength, respectively. Rg is the radius
of gyration, which was determined using the Guinier approximation of the data in
the low s region (sRgo1.3), the linearity of which also served as an initial
assessment of data quality (Supplementary Fig. 4g). The maximum particle
dimension, Dmax, and the distance distribution function, P(r), were calculated using
auto GNOM52 (Supplementary Fig. 4h). The low-resolution envelopes of the
ternary complex were produced using DAMMIN53 by directly fitting the reciprocal
space scattering profile. Fifteen DAMMIN models were generated and then aligned
and averaged using DAMAVER and DAMFILT54. Structural figures were prepared
using Chimera55.
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